W8.1_Introduction to Pharmacokinetics Flashcards
Define pharmacokinetics. What are the clinical points of measurements in pharmacokinetics? What would be the basic questions of it?
- Definition: what the body does to the drug
- Clinical endpoints: measuring drug amount/concentration in biological spaces and fluids at specific time
- Where, how much, when does the drug go?
According to the cumulative amount of drug excreted versus time profile in urine or faeces, how can different drug concentrations in plasma be measured? What is the subsequent step?
- Measuring drug concentration in plasma
- LC-MS (liquid chromatography-mass spectrometry) for small molecule drugs
- Immunoassay (ligand binding assay) for antibody drugs
- After measuring -> calibration curve for quantification
According to the pharmacokinetic profile, define therapeutic range, Cmax, Tmax, AUC, and t1/2. How can the route of administration be determined from it?
- Therapeutic range: between MTC (maximum tolerated concentration) and MEC (minimum effective concentration)
- Too low: no treatment effect vs too high: toxicity/ADR
- Cmax: peak/maximum concentration (µg/mL)
- Tmax: time required to reach Cmax (hr)
- AUC: area under curve = total drug exposure across time (used to calculate bioavailability) (µg⋅h/mL)
- t1/2: half-life is the time taken for drug concentration in plasma to reduce by half (used to determine distribution and elimination) (hr)
- Route of administration can be determined by looking at the profile (X absorption? flat/steep? lag time?)
What are the typical phases in a pharmacokinetic profile? Are there any exceptions? What is the use of pharmacokinetics in a clinical setting?
- 0 -> onset time: absorption lag time
- Onset time -> Tmax: absorption phase
- Tmax -> 0: elimination phase
- Exception: prolonged-release drugs (phases overlap and hard to distinguish)
- Use of pharmacokinetics: dose adjustment for renal repairment
Contrast pharmacokinetic and pharmacodynamic variabilities by giving examples.
Pharmacokinetic variability
- Compliance
- Dosing or medication errors
- Tissue and body fluid mass and volume
- Drug interactions
Pharmacodynamic variability
- Drug receptor status
- Genetic factors
- Drug interactions
- Tolerance